Lilly to buy Calytrix Bio for $1.5 billion
LLY•Eli Lilly will acquire privately held Calytrix Bio for $1.5 billion in cash.
1. Cash acquisition
Eli Lilly will acquire privately held Calytrix Bio for $1.5 billion in cash, Calytrix said.
LLY•Eli Lilly will acquire privately held Calytrix Bio for $1.5 billion in cash.
Eli Lilly will acquire privately held Calytrix Bio for $1.5 billion in cash, Calytrix said.